The COVID-19 pandemic has shown the world how valuable and important infection prevention programs are. In addition to handling routine threats such as flu season and healthcare associated infections, infection prevention and control programs around the world have shifted into overdrive to fight the pandemic and keep communities healthy.
Administering antimicrobial therapy is essential for treating the underlying infections that cause sepsis, but the protocols for doing so can, at times, clash with antimicrobial stewardship guidelines.
COVID-19 is not just any respiratory virus. Researchers have quickly discovered that it is capable of directly affecting multiple organ systems, and that it can also cause a host of related complications. Among those complications are endothelial dysfunction, sepsis, and acute kidney injury.
Antibiotic resistant infections and multi-drug resistant infections have been on the rise in recent years. When it comes to sepsis, these infections have the potential to be much more dangerous because they can be difficult to treat.